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Setting the research agenda for
women and children: the role of Health
Technology Assessment
Imti Choonara,1 Tom Kenny2
Research is essential in that it is required
to provide the scientiﬁc evidence that
helps ensure patients receive the appropri-
ate treatment. Evidence based medicine is
now recognised as essential for all
patients. Historically, both pregnant
women and paediatric patients have been
neglected by researchers. Clinical trials are
more challenging in both of these patient
groups. Additionally, the ﬁnancial rewards
for the pharmaceutical industry have been
smaller due to the smaller market and
need for greater formulations, especially
in paediatric patients. Legislation in both
the USA and the European Union has
given ﬁnancial incentives to the pharma-
ceutical industry to study medicinal pro-
ducts in paediatric patients. The aim of
this article is to discuss how research to
beneﬁt women and children can be
increased and strengthened.
THE NIHR HTA PROGRAMME
The National Institute of Health Research
(NIHR) plays a key role in promoting
research in the UK. Within the NIHR, the
Health Technology Assessment (NIHR
HTA) Programme has been in existence
for 20 years. Many health professionals
unfortunately are confused by the term
‘technology’. A technology is a variety of
interventions. It includes medicinal pro-
ducts but also other interventions such as
diet, physiotherapy, speech therapy, surgi-
cal procedures and medical devices. The
NIHR HTA Programme exists in order to
compare different technologies. In some
cases, this will be a direct comparison of
two different technologies. In other cases,
it will be a comparison of one technology
against placebo.
WHERE IS RESEARCH NEEDED?
Clinical research should eventually result
in improved clinical outcomes, that is,
reduced mortality and morbidity for
both individual patients and the
population as a whole. Both children and
pregnant women have signiﬁcantly higher
mortality rates in the UK than in other
Western European countries such as
Sweden. WHO data for under ﬁve mor-
tality rates in children are ﬁve per 1000
live births in the UK and only three in
Sweden.1 The maternal mortality rate is
three times higher in the UK than in
Sweden.1 Investigator driven research is
an essential part of research and has
resulted in numerous clinical beneﬁts.
There are numerous funding bodies that
encourage academic investigators to
apply for funding in relation to their
research interests. The clinical areas
involved in this investigator driven
research are usually those areas of
research that have historically been well
funded. Unfortunately, many diseases and
disease areas have historically been
neglected by researchers.
DISABILITY-ADJUSTED LIFE YEAR
In order to quantify the burden of disease
in relation to mortality and morbidity, the
metric disability-adjusted life year (DALY)
is used. One DALY is equivalent to one lost
year of healthy life. WHO uses DALYs in
order to quantify the burden of disease.2
For women between the ages of 15 and
44 years in high income countries, mental
health problems are the most signiﬁcant
cause of DALYs. Research into mental
health issues, however, is less well funded
than research into malignancies which
cause fewer DALYs than mental health pro-
blems in young adult women. In children
in high income countries, the main causes
of DALYs are mental health problems and
asthma.2 Unfortunately, as for women,
research funding for children does not cor-
relate well with DALYs and less money is
spent on research into mental health dis-
eases than other less common conditions.
COMMISSIONING RESEARCH
In order to help ensure that research occurs
in neglected areas, the NIHR HTA commis-
sions research to ﬁll in the gaps. Examples of
such commissioned research include the use
of melatonin in children with sleeping
disorders and neurodevelopmental delay.3
Although melatonin did increase total sleep
time by just over 20 min, it was associated
with earlier waking times.3Melatonin signiﬁ-
cantly reduced the time taken to fall asleep.
This research was initially commissioned in
2004, the clinical trial conducted between
2007 and 2011, and published in 2012.3
Another recent clinical trial evaluated
the beneﬁt of ion-exchange water softeners
for the treatment of atopic eczema in chil-
dren. The study involving over 300 chil-
dren with eczema showed there was no
objective difference in outcomes between
children whose homes were ﬁtted with a
water softener and those without.4
As well as commissioning clinical trials,
the NIHR HTA commissions systematic
reviews and meta-analyses. A systematic
review and meta-analysis evaluated the
effects of dietary and lifestyle interventions
in pregnancy for women who are over-
weight or obese on maternal and fetal
weight.5 Dietary interventions were more
effective than physical activity in reducing
maternal gestational weight gain.5 The
interventions also resulted in a signiﬁcant
reduction in the risk of pre-eclampsia.
Additionally, there was no adverse effect on
the risk of babies being born small for ges-
tational age. The importance of this area of
research is highlighted by the fact that half
of the women who die during pregnancy in
the UK are either obese or overweight.
HOW TO SUGGEST A RESEARCH IDEA
The NIHR HTA has recently revised its
panels that review research. A Maternal,
Neonatal and Child Health panel has
been established with a speciﬁc focus on
paediatric patients of all ages (including
neonates) as well as diseases affecting
women during pregnancy. The panel is
keen to receive suggestions for areas of
research via the NIHR HTA website
(http://www.hta.ac.uk). Any individual can
suggest an area of research. Additionally,
special interest groups can suggest areas of
research. All the proposals are reviewed
and discussed. Where there is a clear need
for research that is likely to beneﬁt
patients within the National Health
Service (NHS), then the research proposal
is commissioned, that is, the proposal is
advertised and applications are invited. It
is important to recognise that many
research proposals are not commissioned
as they represent major areas of interest
for the investigator but are not deter-
mined to be of signiﬁcant importance to
patients within the NHS. We do hope,
however, that health professionals will
consider suggesting their ideas. We par-
ticularly welcome suggestions from health
professionals who do not wish to carry
out the research themselves but feel the
research will beneﬁt patients.
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